William Blair restated their outperform rating on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a research note published on Monday, RTT News reports. ALNY has been the subject of several other reports. HC Wainwright reaffirmed a buy rating and issued a $395.00 target price on shares of Alnylam Pharmaceuticals in a research report […]
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the twenty analysts that are covering the firm, MarketBeat reports. Seven research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average 1 year price objective among […]
Asset Management One Co. Ltd. grew its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 2.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 49,405 shares of the biopharmaceutical company’s stock after acquiring an additional 1,027 […]
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its target price cut by Evercore ISI from $252.00 to $210.00 in a research note issued to investors on Tuesday morning, FlyOnTheWall reports. Other equities research analysts also recently issued research reports about the stock. Citigroup decreased their target price on shares of Alnylam Pharmaceuticals from $266.00 to […]
Evercore ISI Lowers Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $210 00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.